(Q34628135)

3 August 2017

1 reference

title

Novel pharmacotherapy for fibromyalgia (English)

1 reference

3 August 2017

0 references

0 references

Patrick B Wood

1

1 reference

3 August 2017

Andrew J Holman

series ordinal

2

1 reference

3 August 2017

Kim D Jones

series ordinal

3

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 June 2007

1 reference

Expert Opinion on Investigational Drugs

3 August 2017

1 reference

3 August 2017

16

1 reference

3 August 2017

6

1 reference

3 August 2017

829-841

1 reference

The prevalence and characteristics of fibromyalgia in the general population.

3 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Biology and therapy of fibromyalgia. New therapies in fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Treatment of fibromyalgia: a changing of the guard

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Chronic widespread pain and fibromyalgia: what we know, and what we need to know

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Vagal modulation of nociception is mediated by adrenomedullary epinephrine in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Circadian studies of autonomic nervous balance in patients with fibromyalgia: a heart rate variability analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Effects of the N-methyl-D-aspartate receptor antagonist dextromethorphan on temporal summation of pain are similar in fibromyalgia patients and normal control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

The effect of maximal exercise on temporal summation of second pain (windup) in patients with fibromyalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Neuroendocrine perturbations in fibromyalgia and chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Overall fibromyalgia pain is predicted by ratings of local pain and pain-related negative affect--possible role of peripheral tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Pain analysis in patients with fibromyalgia. Effects of intravenous morphine, lidocaine, and ketamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Cerebrospinal fluid levels of opioid peptides in fibromyalgia and chronic low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Changes in the concentrations of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia: implications for nitric oxide pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Neurophysiological, pharmacological and behavioral evidence for medial thalamic mediation of cocaine-induced dopaminergic analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

The role of the basal ganglia in nociception and pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Dopamine and NMDA systems modulate long-term nociception in the rat anterior cingulate cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

The role of stress in the pathophysiology of the dopaminergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Stress and dopamine: implications for the pathophysiology of chronic widespread pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Reduced presynaptic dopamine activity in fibromyalgia syndrome demonstrated with positron emission tomography: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Variations in the human pain stress experience mediated by ventral and dorsal basal ganglia dopamine activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Clinical evidence for cervical myelopathy due to Chiari malformation and spinal stenosis in a non-randomized group of patients with the diagnosis of fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Functional abnormalities of the cervical cord and lower medulla and their effect on pain: observations in chronic pain patients with incidental mild Chiari I malformation and moderate to severe cervical cord compression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Supraspinal contributions to hyperalgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Spinal and supraspinal contributions to central sensitization in peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

The role of alpha1- and alpha2-adrenoreceptors on venlafaxine-induced elevation of extracellular serotonin, noradrenaline and dopamine levels in the rat prefrontal cortex and hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Pharmacokinetic and pharmacodynamic profiles of the novel serotonin and norepinephrine reuptake inhibitor desvenlafaxine succinate in ovariectomized Sprague-Dawley rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Venlafaxine Treatment of Fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Evaluation of reboxetine, a noradrenergic antidepressant, for the treatment of fibromyalgia and chronic low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

A randomized, placebo-controlled trial of bupropion sustained release in chronic low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

The slow and long-lasting blockade of dopamine transporters in human brain induced by the new antidepressant drug radafaxine predict poor reinforcing effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

An internet survey of 2,596 people with fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol/acetaminophen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

A reconsideration of the relevance of systemic low-dose ketamine to the pathophysiology of fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Clinical pharmacokinetics of ropinirole

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Effect of pramipexole in treatment of resistant restless legs syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

The interaction between respiratory and autonomic function during sleep-related changes in pharyngeal airway patency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Autonomic dysfunction in spinal cord injury: clinical presentation of symptoms and signs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Restless legs syndrome: treatment with dopaminergic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Mesolimbic dopaminergic mechanisms and pain control

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

The gamma-hydroxybutyrate signalling system in brain: organization and functional implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Musculosketal Symptoms and Non-REM Sleep Disturbance in Patients with “Fibrositis Syndrome” and Healthy Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Induction of Neurasthenic Musculoskeletal Pain Syndrome by Selective Sleep Stage Deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Effect of gamma-hydroxybutyrate on dopamine and dopamine metabolites in the rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Baclofen and gamma-hydroxybutyrate: similar effects on cerebral dopamine neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Naloxone reverses the inhibitory effect of gamma-hydroxybutyrate on central DA release in vivo in awake animals: a microdialysis study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

The effects of gamma-hydroxybutyrate on the membrane properties of guinea-pig pars compacta neurons in the substantia nigra in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

“Dopamine-Dependent” Side Effects of Selective Serotonin Reuptake Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.829

10.1517/13543784.16.6.829

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference